Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?
Hematology Am Soc Hematol Educ Program (2021) 2021 (1): 435–438.
Currently there are no citedby results. Try again later.
